These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 30939084)

  • 21. Phenomenological experiences associated with hypnotic susceptibility.
    Varga K; Józsa E; Bányai EI; Gösi-Greguss AC; Kumar VK
    Int J Clin Exp Hypn; 2001 Jan; 49(1):19-29. PubMed ID: 11190789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Valencia Scale of Attitudes and Beliefs Toward Hypnosis-Client version and hypnotizability.
    Green JP
    Int J Clin Exp Hypn; 2012; 60(2):229-40. PubMed ID: 22443527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A validation study of a short-form hypnotic-experience questionnaire and its relationship to hypnotizability.
    Matheson G; Shue KL; Bart C
    Am J Clin Hypn; 1989 Jul; 32(1):17-26. PubMed ID: 2773816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spanish norms for the Harvard Group Scale of Hypnotic Susceptibility, Form A.
    Lamas JR; del Valle-Inclan F; Blanco MJ; Diaz AA
    Int J Clin Exp Hypn; 1989 Jul; 37(3):264-73. PubMed ID: 2753576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypnotizability, sleepiness, and subjective experience.
    Móró L; Noreika V; Revonsuo A; Kallio S
    Int J Clin Exp Hypn; 2011 Apr; 59(2):211-24. PubMed ID: 21390980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finnish norms for the Harvard Group Scale of Hypnotic Susceptibility, Form A.
    Kallio SP; Ihamuotila MJ
    Int J Clin Exp Hypn; 1999 Jul; 47(3):227-35. PubMed ID: 10616256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A tape-recorded test of hypnotic susceptibility for screening headache patients: a feasibility study of the Harvard Group Scale of Hypnotic Susceptibility, Form A.
    Primavera JP; Patterson S
    Headache; 1991 Oct; 31(9):619-21. PubMed ID: 1774181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A short, unobtrusive hypnotic-assessment procedure for assessing hypnotizability level: I. Development and research.
    Pekala RJ
    Am J Clin Hypn; 1995 Apr; 37(4):271-83. PubMed ID: 7741083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Harvard Group Scale of Hypnotic Susceptibility and related instruments: individual and group administrations.
    Angelini FJ; Kumar VK; Chandler L
    Int J Clin Exp Hypn; 1999 Jul; 47(3):236-50. PubMed ID: 10616257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the sense of agency during hypnosis: The Hungarian version of the Sense of Agency Rating Scale (SOARS-HU) and its relationship with phenomenological aspects of consciousness.
    Költő A; Polito V
    Conscious Cogn; 2017 Mar; 49():245-254. PubMed ID: 28226290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Belgian norms for the Waterloo-Stanford Group C (WSGC) Scale of Hypnotic Susceptibility.
    de Saldanha da Gama PA; Davy T; Cleeremans A
    Int J Clin Exp Hypn; 2012; 60(3):356-69. PubMed ID: 22681330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Elkins Hypnotizability Scale: Assessment of Reliability and Validity.
    Kekecs Z; Bowers J; Johnson A; Kendrick C; Elkins G
    Int J Clin Exp Hypn; 2016; 64(3):285-304. PubMed ID: 27267674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Israeli norms for the Stanford hypnotic susceptibility scale, Form C.
    Lichtenberg P; Shapira H; Kalish Y; Abramowitz EG
    Int J Clin Exp Hypn; 2009 Apr; 57(2):227-37. PubMed ID: 19234969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationships of hypnotic susceptibility to paranormal beliefs and claimed experiences: implications for hypnotic absorption.
    Atkinson RP
    Am J Clin Hypn; 1994 Jul; 37(1):34-40. PubMed ID: 8085544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypnotizability and absorption in a Danish sample: testing the influence of context.
    Zachariae R; Jørgensen MM; Christensen S
    Int J Clin Exp Hypn; 2000 Jul; 48(3):306-14. PubMed ID: 10902295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct and indirect scales of hypnotic susceptibility: resistance to therapy and psychometric comparability.
    Robin BR; Kumar VK; Pekala RJ
    Int J Clin Exp Hypn; 2005 Apr; 53(2):135-47. PubMed ID: 16025732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcultural Factors in Hypnotizability Scales: Limits and Prospects.
    Champigny CM; Raz A
    Am J Clin Hypn; 2015 Oct; 58(2):171-94. PubMed ID: 26264541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Can hypnotic susceptibility be explained by bifactor models? Structural equation modeling of the Harvard group scale of hypnotic susceptibility - Form A.
    Zahedi A; Sommer W
    Conscious Cogn; 2022 Mar; 99():103289. PubMed ID: 35193060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Waterloo-Stanford Group C (WSGC) scale of hypnotic susceptibility: normative and comparative data.
    Bowers KS
    Int J Clin Exp Hypn; 1993 Jan; 41(1):35-46. PubMed ID: 8425774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Translation, adaptation, and validation of the Stanford Hypnotic Clinical Scale in Puerto Rico.
    Deynes-Exclusa Y; Sayers-Montalvo SK; Martinez-Taboas A
    Int J Clin Exp Hypn; 2011 Apr; 59(2):266-75. PubMed ID: 21390984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.